Raburn Mallory

Raburn Mallory, M.D. has extensive work experience in the field of Clinical Development and Infectious Disease. Raburn currently holds the position of Senior Vice President & Head of Clinical Development at NOVAVAX. Prior to that, they worked as the Vice President, Clinical Development Infectious Disease & Vaccines at AstraZeneca. In this role, they were responsible for the development and management of various global clinical programs, including the Coronavirus vaccine and the Flumist vaccine. Before joining AstraZeneca, Dr. Mallory served as the Director at Dynport Vaccine Company, where they coordinated clinical development activities for vaccines and oversaw study execution. Raburn also has experience working as a Consultant at McKinsey & Company, where they focused on healthcare strategy, and as a Robert Wood Johnson Clinical Scholar at Johns Hopkins University. Dr. Mallory began their career as a Resident/Chief Resident at Yale-New Haven Hospital and as a Howard Hughes Research Fellow at Yale University School of Medicine.

Raburn Mallory, M.D. obtained a Bachelor of Arts (B.A.) degree in Art History from Brown University in 1988. Following this, they attended Yale University School of Medicine from 1995 to 1997, earning their Doctor of Medicine (M.D.) degree. Prior to their undergraduate studies, they attended Westminster School in London from 1979 to 1983.